About AustinPx
AustinPx™, Pharmaceutics and Manufacturing, was founded to help developers realize the full potential of their drug candidates. There are many obstacles to bringing a drug to market, including poor bioavailability and accelerated timelines. That’s where we come in. Our client-centric approach is designed to simplify the complexity of outsourcing and our team of formulation, analytical and manufacturing experts work with you to overcome challenges and identify opportunities to do more, faster. As the inventors of the KinetiSol® Technology - a next generation amorphous solid dispersion (ASD) technology for poorly soluble APIs - we look to disrupt the ASD industry with its smaller footprint, broader design space, and greener processing solution.
Leadership at AustinPx
The team at the top of the org chart.
Elizabeth Hickman
Chief Executive Officer
24 reports
Chris Brough
Chief Technology Officer (cto)
4 reports
Dave A. Miller
Chief Scientific Officer (cso)
4 reports
Justin M. Keen
Senior Vice President, Operations
5 reports
Francesco Sherod
Vice President, Finance
3 reports
Angela Hoffnagle
Marketing Director
Rob Rigney
Executive Director
2 reports